ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BVC Batm Advanced Communications Ld

20.60
0.00 (0.00%)
Last Updated: 10:57:53
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Batm Advanced Communications Ld LSE:BVC London Ordinary Share IL0010849045 ORD ILS0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 20.60 20.00 20.50 - 8,874 10:57:53
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Communications Services, Nec 122.83M -193k -0.0004 -515.00 89.82M
Batm Advanced Communications Ld is listed in the Communications Services sector of the London Stock Exchange with ticker BVC. The last closing price for Batm Advanced Communicat... was 20.60p. Over the last year, Batm Advanced Communicat... shares have traded in a share price range of 15.75p to 30.55p.

Batm Advanced Communicat... currently has 436,039,124 shares in issue. The market capitalisation of Batm Advanced Communicat... is £89.82 million. Batm Advanced Communicat... has a price to earnings ratio (PE ratio) of -515.00.

Batm Advanced Communicat... Share Discussion Threads

Showing 41601 to 41619 of 47275 messages
Chat Pages: Latest  1675  1674  1673  1672  1671  1670  1669  1668  1667  1666  1665  1664  Older
DateSubjectAuthorDiscuss
23/8/2021
15:28
Also on the eco med, they were still struggling with travel restrictions to work with the customers in the Philippines and Taiwan, but CEVA was back on track.
paulisi
23/8/2021
15:26
The work with Ceva animal health is a positive sign for the eco med division. Working with the big names
doccash
23/8/2021
15:26
Once NFV sales kick in, margins will jump. They quoted 85% on the subscription model.Also the said they were doing more proof of concept tests and further announcements would be imminent.I think they said the Romania lab was expanding into Hungary.
paulisi
23/8/2021
15:04
The new all in one respiratory test will be selling in winter and that should be another money spinner. Seemed confidant of working with other big telecoms and service providers.
doccash
23/8/2021
14:49
I attended the webinar and asked about the dividend.It will be announced at the AGM, but some money is going towards R&D and potential acquisitions in both divisionsNot too many questions asked, but they expect to see substantial growth on NFV. Revenue on monthly subscription basis. Expect to see it ramp up to hundreds of thousands of subscriptions in a few years time.Diagnostics is still growing and expecting to be the majority of the revenue for full year.
paulisi
23/8/2021
14:41
Good man, Doc.
lsoc85
23/8/2021
14:14
From webinar
doccash
23/8/2021
14:13
Dividend to be announced after AGM
doccash
23/8/2021
14:07
It's not about the money received, it's about signalling his and the Board's confidence in the operation going forward.
lsoc85
23/8/2021
13:49
dividend - i didn't choose this investment for that.
nellyb
23/8/2021
13:16
Nothing new in that interview.See what the webinar tells us
paulisi
23/8/2021
08:32
Expecting price to dip after initial surge and probably close around 89-90pWill surge again when tipped by IC next week.
paulisi
23/8/2021
08:22
According to this article, expecting revenue close to 250m
paulisi
23/8/2021
08:03
Initial price up around 5%
paulisi
23/8/2021
08:02
Dr Zvi Marom, Chief Executive Officer, and Moti Nagar, Chief Financial Officer, will be holding a webinar for analysts and investors today at 2.00pm BST. To register to participate, please contact Tanweer Siddique at Luther Pendragon at tanweersiddique@luther.co.uk
nellyb
23/8/2021
07:52
"Looking ahead, we entered the second half with a strong order book and receiving sustained demand for our diagnostic solutions. We also continue to expect to generate revenue this year from the roll-out of Edgility OS by PCCW Global. As a result, we anticipate achieving better-than-expected revenue for the full year and EBITDA to be substantially ahead of market expectations with growth of over 40% year-on-year. Consequently, and supported by a robust balance sheet, the Board of BATM continues to look to the future with great confidence.
steeplejack
23/8/2021
07:40
Lot of smoke and mirrors - why could they not just take out the £13m gain and one off Oxygen profit.
zipstuck
23/8/2021
07:28
Difficult to know how to interpret these results with NG Soft sale and ventilators coming out of the accounts and the impact of lockdowns.Medical division growing with NATLAB revenues to kick in and TB test coming on line.Tech side still loss making and flat on revenues, but substantial growth expected through NFV and cyberMargins significantly upPlenty of cash in the bank. No mention of dividend or bolt on acquisitionsFull year ahead of expectations.Not sure what the markets will make of it
paulisi
22/8/2021
23:04
Difficulties in sourcing components may have impacted orders, no guidance on divi, no major new contracts announced, not sure what tomorrow will bring.
picsous
Chat Pages: Latest  1675  1674  1673  1672  1671  1670  1669  1668  1667  1666  1665  1664  Older

Your Recent History

Delayed Upgrade Clock